Researchers at Georgetown University have developed a new drug called CTPI-2, which targets a key gene known as Slc25a1. This ...

Madrigal Pharmaceuticals has been given Food and Drug Administration market clearance for its experimental treatment for NASH ...

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has become the first drug to be approved by the US Food and Drug Administration (FDA) as a treatment for noncirrhotic nonalcoholic ...

He believes that NASH treatment is destined to progress rapidly towards combination treatment, just as hep C has, and that these doctors “wrote the book” on how to combine two unapproved ...

ACLY inhibitors also show potential in NASH treatment. Sino Biological provides recombinant NASH-related drug targets to support drug discovery and study the interactions between these targets ...

Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA), a clinical stage biopharmaceutical company that has been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC” ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

which is also developing a NASH treatment. Allergan in September bought two biotechs developing NASH drugs, Tobira and Akarna. The FDA has fast-tracked Shire’s early stage NASH drug ...

This might imply that NASH is the shared end result of varying ... If this hypothesis is true, we should try to tailor treatment to each subject. We hypothesized that analysis of morphological ...

Considering taking supplements to treat nonalcoholic steatohepatitis nash? Below is a list of common natural remedies used to treat or reduce the symptoms of nonalcoholic steatohepatitis nash.